The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 31 results:
[ Author(Desc)] Title Type Year
Filters: Author is Georgianos, Panagiotis I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Georgianos, P. I., Vaios V., Eleftheriadis T., Papachristou E., & Liakopoulos V. (2023).  Therapeutic Advances in Diabetic Kidney Disease.. Int J Mol Sci. 24(3), 
Georgianos, P. I., Sarafidis P. A., Malindretos P., Nikolaidis P., & Lasaridis A. N. (2011).  Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients.. Am J Nephrol. 34(5), 407-14.
Georgianos, P. I., Sarafidis P. A., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2016).  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.. J Clin Hypertens (Greenwich). 18(3), 197-9.
Georgianos, P. I., Vaios V., Leontaridou E., Karayannopoulou G., Koletsa T., Sioulis A., et al. (2019).  Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.. Case Rep Nephrol. 2019, 3614980.
Georgianos, P. I., Papachristou E., & Liakopoulos V. (2023).  Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?. Hypertens Res. 46(4), 890-892.
Georgianos, P. I., Sarafidis P. A., & Zebekakis P. E. (2014).  Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.. J Clin Hypertens (Greenwich). 16(7), 475-6.
Georgianos, P. I., Liampas I., Kyriakou A., Vaios V., Raptis V., Savvidis N., et al. (2017).  Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.. Int Urol Nephrol. 49(12), 2217-2221.
Georgianos, P. I., Vaios V., Zebekakis P. E., & Liakopoulos V. (2020).  Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations.. J Clin Hypertens (Greenwich). 22(5), 924-928.
Georgianos, P. I., Sarafidis P. A., Sinha A. D., & Agarwal, iv R. (2015).  Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?. Am J Nephrol. 41(4-5), 400-8.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
Georgianos, P. I., Vaios V., Sgouropoulou V., Eleftheriadis T., Tsalikakis D. G., & Liakopoulos V. (2022).  Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology.. Diagnostics (Basel). 12(12), 
Georgianos, P. I., Sarafidis P. A., Karpetas A., Kosmidis D., Sioulis A., Liakopoulos V., et al. (2014).  Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures.. Blood Purif. 37(1), 18-26.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P., & Liakopoulos V. (2017).  Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence.. Curr Vasc Pharmacol. 15(6), 599-606.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P. E., & Liakopoulos V. (2020).  Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence.. Curr Vasc Pharmacol.
Georgianos, P. I., Tziatzios G., Roumeliotis S., Vaios V., Sgouropoulou V., Tsalikakis D. G., et al. (2023).  Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.. Nephrol Dial Transplant. 38(1), 203-211.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Georgianos, P. I., Pikilidou M. I., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.. Hypertens Res. 41(5), 309-319.
Georgianos, P. I., Vaios V., Divani M., & Liakopoulos V. (2023).  Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?. Expert Opin Pharmacother.
Georgianos, P. I., Sarafidis P. A., & Lasaridis A. N. (2013).  Arterial Stiffness: a Novel Cardiovascular Risk Factor in Kidney Disease Patients.. Curr Vasc Pharmacol.
Georgianos, P. I., Morfesis P., & Zebekakis P. E. (2017).  Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?. J Hypertens. 35(3), 650-651.
Georgianos, P. I., Liakopoulos V., & Zebekakis P. E. (2019).  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.. J Clin Hypertens (Greenwich). 21(2), 249-251.
Georgianos, P. I., Vaios V., Sgouropoulou V., & Liakopoulos V. (2022).  The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria.. J Hypertens. 40(7), 1432-1433.
Georgianos, P. I., & Sarafidis P. A. (2015).  Opponent's comment.. Nephrol Dial Transplant. 30(1), 27-8.
Georgianos, P. I., Champidou E., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.. J Am Soc Hypertens. 12(4), 242-247.
Georgianos, P. I., Dounousi E., & Liakopoulos V. (2023).  Albuminuria and cardiorenal risk.. Curr Opin Cardiol.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.